Literature DB >> 11751440

Metabolic gene polymorphism frequencies in control populations.

S Garte1, L Gaspari, A K Alexandrie, C Ambrosone, H Autrup, J L Autrup, H Baranova, L Bathum, S Benhamou, P Boffetta, C Bouchardy, K Breskvar, J Brockmoller, I Cascorbi, M L Clapper, C Coutelle, A Daly, M Dell'Omo, V Dolzan, C M Dresler, A Fryer, A Haugen, D W Hein, A Hildesheim, A Hirvonen, L L Hsieh, M Ingelman-Sundberg, I Kalina, D Kang, M Kihara, C Kiyohara, P Kremers, P Lazarus, L Le Marchand, M C Lechner, E M van Lieshout, S London, J J Manni, C M Maugard, S Morita, V Nazar-Stewart, K Noda, Y Oda, F F Parl, R Pastorelli, I Persson, W H Peters, A Rannug, T Rebbeck, A Risch, L Roelandt, M Romkes, D Ryberg, J Salagovic, B Schoket, J Seidegard, P G Shields, E Sim, D Sinnet, R C Strange, I Stücker, H Sugimura, J To-Figueras, P Vineis, M C Yu, E Taioli.   

Abstract

Using the International Project on Genetic Susceptibility to Environmental Carcinogens (GSEC) database containing information on over 15,000 control (noncancer) subjects, the allele and genotype frequencies for many of the more commonly studied metabolic genes (CYP1A1, CYP2E1, CYP2D6, GSTM1, GSTT1, NAT2, GSTP, and EPHX) in the human population were determined. Major and significant differences in these frequencies were observed between Caucasians (n = 12,525), Asians (n = 2,136), and Africans and African Americans (n = 996), and some, but much less, heterogeneity was observed within Caucasian populations from different countries. No differences in allele frequencies were seen by age, sex, or type of controls (hospital patients versus population controls). No examples of linkage disequilibrium between the different loci were detected based on comparison of observed and expected frequencies for combinations of specific alleles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751440

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  225 in total

1.  Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients.

Authors:  Varvara I Minina; Olga A Soboleva; Andrey N Glushkov; Elena N Voronina; Ekaterina A Sokolova; Marina L Bakanova; Yana A Savchenko; Anastasia V Ryzhkova; Ruslan A Titov; Vladimir G Druzhinin; Maxim Yu Sinitsky; Maxim A Asanov
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-02       Impact factor: 4.553

Review 2.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.

Authors:  Hermann M Bolt; Peter H Roos; Ricarda Thier
Journal:  Int Arch Occup Environ Health       Date:  2003-03-01       Impact factor: 3.015

3.  Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population.

Authors:  Ahmet O Ada; Semih C Kunak; Figen Hancer; Emre Soydas; Sibel Alpar; Meral Gulhan; Mumtaz Iscan
Journal:  Mol Biol Rep       Date:  2011-12-30       Impact factor: 2.316

Review 4.  Hormonal therapy in breast cancer: a model disease for the personalization of cancer care.

Authors:  Shannon Puhalla; Saveri Bhattacharya; Nancy E Davidson
Journal:  Mol Oncol       Date:  2012-02-24       Impact factor: 6.603

5.  Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.

Authors:  Al-Motassem Yousef; Nailya R Bulatova; William Newman; Nancy Hakooz; Said Ismail; Hisham Qusa; Farah Zahran; Nidaa Anwar Ababneh; Farah Hasan; Imad Zaloom; Ghada Khayat; Rawan Al-Zmili; Randa Naffa; Ola Al-Diab
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

6.  Lack of association between GSTT1 polymorphism and endogenous or benzo[a]pyrene-induced sister chromatid exchanges as analyzed in metaphase or G2-phase lymphocytes.

Authors:  V I Hatzi; G I Terzoudi; C Stavropoulou; S I Malik; V Makropoulos; G E Pantelias
Journal:  Mol Biol Rep       Date:  2010-11-25       Impact factor: 2.316

7.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

8.  Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.

Authors:  Nikhil K Khankari; Patrick T Bradshaw; Lauren E McCullough; Susan L Teitelbaum; Susan E Steck; Brian N Fink; Xinran Xu; Jiyoung Ahn; Christine B Ambrosone; Katherine D Crew; Mary Beth Terry; Alfred I Neugut; Jia Chen; Regina M Santella; Marilie D Gammon
Journal:  Cancer Causes Control       Date:  2013-11-27       Impact factor: 2.506

9.  Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study.

Authors:  Raul Zamora-Ros; Nitin Shivappa; Susan E Steck; Federico Canzian; Stefano Landi; M Henar Alonso; James R Hébert; Victor Moreno
Journal:  Genes Nutr       Date:  2014-12-09       Impact factor: 5.523

10.  High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.

Authors:  Teresita Díaz de Ståhl; Caisa M Hansson; Cecilia de Bustos; Kiran K Mantripragada; Arkadiusz Piotrowski; Magdalena Benetkiewicz; Caroline Jarbo; Leif Wiklund; Tiit Mathiesen; Gunnar Nyberg; V Peter Collins; D Gareth Evans; Koichi Ichimura; Jan P Dumanski
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.